Please use this identifier to cite or link to this item:
Title: Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection : a systematic review and meta-analysis of individual participant data.
Authors: Sguassero, Yanina
Roberts, Karen N.
Harvey, Guillermina B.
Comandé, Daniel
Cuesta, Cristina B.
Aguiar, Camila
Castro, Ana M. de
Danesi, Emmaría
Andrade, Ana L. de
Lana, Marta de
Escribà, Josep M.
Fabbro, Diana L.
Fernandes, Cloé Duarte
Flores Chávez, María
Hasslocher Moreno, Alejandro Marcel
Jackson, Yves Laurent
Assis, Girley Francisco Machado de
Maldonado, Marisel
Meira, Wendell Sérgio Ferreira
Molina, Israel
Monje Rumi, María Mercedes
Muñoz San Martín, Catalina
Murcia, Laura
Castro, Cleudson Nery de
Negrette, Olga Sánchez
Segovia, Manuel
Silveira, Celeste Aída Nogueira
Solari, Aldo
Steindel, Mário
Streiger, Mirtha Leonor
Bilbao, Ninfa Vera de
Zulantay, Inés
Sosa Estani, Sergio
Keywords: Chronic disease
Follow-up studies
Issue Date: 2018
Citation: SGUASSERO, Y. et al. Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection : a systematic review and meta-analysis of individual participant data. International Journal of Infectious Diseases, v. 73, p. 93-101, ago. 2018. Disponível em: <>. Acesso em: 21 fev. 2019.
Abstract: Objective To determine the course of serological tests in subjects with chronic Trypanosoma cruzi infection treated with anti-trypanosomal drugs. Methods A systematic review and meta-analysis was conducted using individual participant data. Survival analysis and the Cox proportional hazards regression model with random effects to adjust for covariates were applied. The protocol was registered in the PROSPERO database (; CRD42012002162). Results A total of 27 studies (1296 subjects) conducted in eight countries were included. The risk of bias was low for all domains in 17 studies (63.0%). Nine hundred and thirteen subjects were assessed (149 seroreversion events, 83.7% censored data) for enzyme-linked immunosorbent assay (ELISA), 670 subjects (134 events, 80.0% censored) for indirect immunofluorescence assay (IIF), and 548 subjects (99 events, 82.0% censored) for indirect hemagglutination assay (IHA). A higher probability of seroreversion was observed within a shorter time span in subjects aged 1–19 years compared to adults. The chance of seroreversion also varied according to the country where the infection might have been acquired. For instance, the pooled adjusted hazard ratio between children/adolescents and adults for the IIF test was 1.54 (95% confidence interval 0.64–3.71) for certain countries of South America (Argentina, Bolivia, Chile, and Paraguay) and 9.37 (95% confidence interval 3.44–25.50) for Brazil. Conclusions The disappearance of anti-T. cruzi antibodies was demonstrated along the course of follow-up. An interaction between age at treatment and country setting was found.
ISSN: 12019712
metadata.dc.rights.license: This is an open access article under the CC BY-NC-ND license ( Fonte: o próprio artigo.
Appears in Collections:DEACL - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ARTIGO_CourseSerologicalTests.pdf1,2 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.